Nobivac Canine 1-DAPPv+L4 Vaccine

Supplied By: Merck (099336)


SKU
038883


Unit of
Measure 25 x 1 Dose


Pack
Type Box


Case
Qty 1

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024
{{purchaseHistoryItem}}


SKU 038883


Size 25 x 1 Dose

Case
Qty 1

Purchase History

Jan- 2025 {{productPurchaseHistory['038883'][0]}} Jun- 2024 {{productPurchaseHistory['038883'][0+7]}}
Dec- 2024 {{productPurchaseHistory['038883'][1]}} May- 2024 {{productPurchaseHistory['038883'][1+7]}}
Nov- 2024 {{productPurchaseHistory['038883'][2]}} Apr- 2024 {{productPurchaseHistory['038883'][2+7]}}
Oct- 2024 {{productPurchaseHistory['038883'][3]}} Mar- 2024 {{productPurchaseHistory['038883'][3+7]}}
Sep- 2024 {{productPurchaseHistory['038883'][4]}} Feb- 2024 {{productPurchaseHistory['038883'][4+7]}}
Aug- 2024 {{productPurchaseHistory['038883'][5]}} Jan- 2024 {{productPurchaseHistory['038883'][5+7]}}
Jul- 2024 {{productPurchaseHistory['038883'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

NOBIVAC® Canine 1-DAPPv+L vaccine is a combination vaccine that unites the benefits of NOBIVAC Canine 1-DAPPv and NOBIVAC Lepto in one vaccination. NOBIVAC Canine 1-DAPPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus, and canine parvovirus. Data indicate the development of corneal opacity is not associated with the use of this product. NOBIVAC Lepto bacterin is recommended for the vaccination of healthy dogs as an aid in the prevention of disease and mortality caused by L. canicola, L. icterohaemorrhagiae, L. pomona, and L. grippotyphosa; the prevention of leptospiruria (shedding of Leptospira in the urine) caused by L. canicola, L. icterohaemorrhagiae, and L. grippotyphosa; and as an aid in the prevention of leptospiruria caused by L. pomona.

Features & Benefits

  • Contains CPV-2b, the most prevalent field strain of parvovirus high antigenic mass (titer)
  • Low passage parvovirus vaccine
  • Overrides maternal antibodies in young puppies
  • The only leptospirosis vaccine as an aid in the prevention of disease and mortality, and prevents urinary shedding
  • Prevented mortality caused by 4 virulent Leptospira serovars